Delays in diagnosis and treatment among children and adolescents with cancer in Canada.

Full Abstract

BACKGROUND:
Few studies have investigated delays in diagnosis and treatment among children and adolescents with cancer, especially from the perspective of an entire country. Detailed understanding of delays along the continuum of cancer patient care is important in order to establish appropriate benchmarks for timely oncological care. Our objective was to characterise the different components of delay in 2,896 Canadian children and adolescents (aged 0-19 years) with cancer that were enrolled in the Treatment and Outcome Surveillance component of the Canadian Childhood Cancer Surveillance and Control Program from 1995 to 2000.

PROCEDURE:
We examined median and standardised means concerning the distribution of delay times across categories of pertinent variables and over time. The word "delay" was used simply to represent a time interval, measured in days, without implying whether this interval exceeded a particular threshold of clinical acceptability.

RESULTS:
The median times (and inter-quartile ranges) for patient, diagnosis and healthcare system delays for all cancers were 9 (1-31), 30 (13-69) and 12 (4-35) days, respectively. The median total delay was 34 (16-76) days.

CONCLUSIONS:
Patient and referral delays were the longest time segments influencing timely diagnosis. Differences in delays were observed across age groups, cancer types and geographical regions. There was a significant trend for decreasing delays to diagnosis and treatment.(c) 2008 Wiley-Liss, Inc.

Learn Faster Today Improve your study skills

Author information

Author/s: Dang-Tan, Tam (T); Trottier, Helen (H); Mery, Leslie S (LS); Morrison, Howard I (HI); Barr, Ronald D (RD); Greenberg, Mark L (ML); Franco, Eduardo L (EL);

Affiliation: Departments of Oncology and Epidemiology, McGill University, Montreal, Canada.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Pediatric blood & cancer (Pediatr Blood Cancer), published in United States. (Language: eng)

Reference: 2008-Oct; vol 51 (issue 4) : pp 468-74

Dates: Created 2008/08/12; Completed 2008/08/29;

PMID: 18454472, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentIn: Pediatr Blood Cancer. 2008 Oct;51(4):447-8. (PMID: 18623208)

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Humans
Infant
Infant, Newborn
Male
Neoplasms - classification; diagnosis; epidemiology; therapy
Time Factors

These are the highest related articles currently in the database:

See 100+ related articles.